CIRHEPZO
LIVE

Serial Number

79419000

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Jan 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CIRHEPZO Trademark

Serial Number: 79419000 • Registration: 8007213

CIRHEPZO is a trademark filed by Bausch Health Ireland Limited on January 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bausch Health Ireland Limited (2 trademarks)

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

January 17, 2025

Registration Date

November 4, 2025

Published for Opposition

September 16, 2025

Goods & Services

pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 22, 2026 FICS
FINAL DISPOSITION PROCESSED
May 22, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 4, 2026 FICR
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Dec 18, 2025 RHRD
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 4, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
REFUSAL PROCESSED BY IB
Aug 29, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 19, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 14, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 13, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 2, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 1, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 13, 2025 REPR